These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 2177343)

  • 21. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.
    Levy L; Hill CS
    Cytokine Growth Factor Rev; 2006; 17(1-2):41-58. PubMed ID: 16310402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Signaling pathways of transforming growth factor beta family members].
    Zimowska M
    Postepy Biochem; 2006; 52(4):360-6. PubMed ID: 17536504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds.
    Cowin AJ; Holmes TM; Brosnan P; Ferguson MW
    Eur J Dermatol; 2001; 11(5):424-31. PubMed ID: 11525949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding and internalization of transforming growth factor-beta 1 by human hepatoma cells: evidence for receptor recycling.
    Sathre KA; Tsang ML; Weatherbee JA; Steer CJ
    Hepatology; 1991 Aug; 14(2):287-95. PubMed ID: 1650327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth regulatory factors and carcinogenesis: the roles played by transforming growth factor beta, its receptors and signaling pathways.
    Kelly DL; Rizzino A
    Anticancer Res; 1999; 19(6A):4791-807. PubMed ID: 10697593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-beta isoform and receptor expression.
    Goldberg SR; McKinstry RP; Sykes V; Lanning DA
    J Pediatr Surg; 2007 Jun; 42(6):966-71; discussion 971-3. PubMed ID: 17560204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
    Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
    Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of the retinoblastoma gene does not lead to loss of TGF-beta receptors or response to TGF-beta in breast cancer cell lines.
    Ong G; Sikora K; Gullick WJ
    Oncogene; 1991 May; 6(5):761-3. PubMed ID: 1646985
    [No Abstract]   [Full Text] [Related]  

  • 31. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
    Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S
    Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of H-ras oncogene induces resistance to the growth-inhibitory action of transforming growth factor beta-1 (TGF-beta 1) and alters the number and type of TGF-beta 1 receptors in rat intestinal epithelial cell clones.
    Filmus J; Zhao J; Buick RN
    Oncogene; 1992 Mar; 7(3):521-6. PubMed ID: 1312703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid.
    Johnson MD; Gold LI; Moses HL
    Lab Invest; 1992 Sep; 67(3):360-8. PubMed ID: 1328762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta.
    Brandes ME; Mai UE; Ohura K; Wahl SM
    J Immunol; 1991 Sep; 147(5):1600-6. PubMed ID: 1652608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta is a potent negative regulator of human lymphocytes.
    Kehrl JH; Taylor A; Kim SJ; Fauci AS
    Ann N Y Acad Sci; 1991; 628():345-53. PubMed ID: 1648884
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of cardiac fibrosis by transforming growth factor-beta(1).
    Lijnen PJ; Petrov VV; Fagard RH
    Mol Genet Metab; 2000; 71(1-2):418-35. PubMed ID: 11001836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmental tumours, early differentiation and the transforming growth factor beta superfamily.
    Mummery CL; van den Eijnden-van Raaij AJ
    Int J Dev Biol; 1999; 43(7):693-709. PubMed ID: 10668979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor-beta: a key mediator of fibrosis.
    Mauviel A
    Methods Mol Med; 2005; 117():69-80. PubMed ID: 16118446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta: latent forms, binding proteins and receptors.
    Miyazono K; Ichijo H; Heldin CH
    Growth Factors; 1993; 8(1):11-22. PubMed ID: 8383513
    [No Abstract]   [Full Text] [Related]  

  • 40. Transforming growth factor-beta: recent progress and new challenges.
    Sporn MB; Roberts AB
    J Cell Biol; 1992 Dec; 119(5):1017-21. PubMed ID: 1332976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.